LISTEN LIVE

DONATE NOW

New Israeli technology improves prediction of patient response to immunotherapy

Ben-Gurion University researchers develop innovative biosensor, team up with Israeli biotech company OncoHost in bid for FDA approval

Send a Voice Response. Please include your name.

Leave a Reply

Your email address will not be published. Required fields are marked *